Financhill
Sell
47

AAOI Quote, Financials, Valuation and Earnings

Last price:
$15.40
Seasonality move :
61.55%
Day range:
$15.06 - $16.70
52-week range:
$6.70 - $44.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.22x
P/B ratio:
2.77x
Volume:
5M
Avg. volume:
3.5M
1-year change:
33.05%
Market cap:
$856.5M
Revenue:
$249.4M
EPS (TTM):
-$3.86

AAOI Analysts' Consensus Rating

The 3 analysts providing 12-month price projections for Applied Optoelectronics shares anticipate an average target of $34.80, ranging from a low estimate of $13.00 to a high estimate of $70.00. This average target implies a growth of 97.15% compared to the current stock price of $15.42.

Consensus Price Target

$34.80

Highest Price Target

$70.00

Lowest Price Target

$13.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 2 2 2

Hold 1 1 1

Sell 0 0 0
Consensus Buy Buy Buy

AAOI Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock